Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


14.06.2021

1 AIDS
8 BMJ
6 Clin Infect Dis
1 Clin Microbiol Rev
1 Indian Pediatr
4 J Infect
1 J Infect Dis
3 J Virol
7 JAMA
7 Lancet
4 MMWR Morb Mortal Wkly Rep
12 N Engl J Med
5 Nat Med
3 Pediatr Infect Dis J
3 Pediatrics
1 PLoS Med
5 PLoS One
4 Proc Natl Acad Sci U S A
2 Science
38 Vaccine
1 Virology
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed         Abstract available


    BMJ

  2. KRISHTEL P, Malpani R
    Suspend intellectual property rights for covid-19 vaccines.
    BMJ. 2021;373:n1344.
    PubMed        

  3. SHEPHERD A
    Protesters call for UK to back covid vaccine waiver.
    BMJ. 2021;373:n1388.
    PubMed        

  4. BLOCK J
    US college covid-19 vaccine mandates don't consider immunity or pregnancy, and may run foul of the law.
    BMJ. 2021;373:n1397.
    PubMed        

  5. MAHASE E
    Covid-19: UK has highest vaccine confidence and Japan and South Korea the lowest, survey finds.
    BMJ. 2021;373:n1439.
    PubMed        

  6. MAHASE E
    Covid-19: Freedom won't last if UK doesn't share excess vaccine doses, aid agencies warn.
    BMJ. 2021;373:n1444.
    PubMed        

  7. MAHASE E
    Childhood vaccination: Access problems in UK began way before covid-19.
    BMJ. 2021;373:n1436.
    PubMed        

  8. LLOYD-SHERLOCK P, Kandiyil NM, McKee M, Perianayagam A, et al
    Pandemic lessons from India: inappropriate prioritisation for vaccination.
    BMJ. 2021;373:n1464.
    PubMed        

  9. WISE J
    Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show.
    BMJ. 2021;373:n1489.
    PubMed        


    Clin Infect Dis

  10. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    PubMed         Abstract available

  11. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    PubMed        

  12. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    PubMed         Abstract available

  13. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    PubMed         Abstract available

  14. MWENDA JM, Hallowell BD, Parashar U, Shaba K, et al
    Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018.
    Clin Infect Dis. 2021 Jun 5. pii: 6293961. doi: 10.1093.
    PubMed         Abstract available

  15. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    PubMed        


    Clin Microbiol Rev

  16. SLACK MPE, Cripps AW, Grimwood K, Mackenzie GA, et al
    Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.
    Clin Microbiol Rev. 2021 Jun 2:e0002821. doi: 10.1128/CMR.00028.
    PubMed         Abstract available


    Indian Pediatr

  17. DHARMAPALAN D, John TJ
    COVID-19 Eradication for Vaccine Equity in Low Income Countries.
    Indian Pediatr. 2021 Jun 10. pii: S097475591600340.
    PubMed         Abstract available


    J Infect

  18. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    PubMed        

  19. PEZZATI L, Giacomelli A, Mileto D, Conti F, et al
    Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: a cross-sectional study.: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
    J Infect. 2021 May 29. pii: S0163-4453(21)00271.
    PubMed        

  20. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    PubMed        

  21. AKPOLAT T, Uzun O
    REDUCED MORTALITY RATE AFTER CORONAVAC VACCINE AMONG HEALTHCARE WORKERS.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00285.
    PubMed        


    J Infect Dis

  22. MARAVELIA P, Frelin L, Ni Y, Perez NC, et al
    Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections.
    J Infect Dis. 2020 Jan 29. pii: 5717223. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  23. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    PubMed         Abstract available

  24. QIN K, Boppana S, Carlson JM, Fiore-Gartland A, et al
    Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting of adapted epitopes.
    J Virol. 2021 Jun 2:JVI0016021. doi: 10.1128/JVI.00160.
    PubMed         Abstract available

  25. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    PubMed         Abstract available


    JAMA

  26. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    PubMed        

  27. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    PubMed        

  28. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    PubMed        

  29. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    PubMed        

  30. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed         Abstract available

  31. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    PubMed        

  32. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    PubMed        


    Lancet

  33. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed        

  34. FORMAN R, Jit M, Mossialos E
    Divergent vaccination policies could fuel mistrust and hesitancy.
    Lancet. 2021 Jun 1. pii: S0140-6736(21)01106.
    PubMed        

  35. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    PubMed        

  36. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    PubMed        

  37. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    PubMed        

  38. WALL EC, Wu M, Harvey R, Kelly G, et al
    Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01290.
    PubMed        

  39. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  40. BARRY V, Dasgupta S, Weller DL, Kriss JL, et al
    Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity - United States, December 14, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:818-824.
    PubMed         Abstract available

  41. O'CONNOR P, Yankovic D, Zimmerman L, Ben Mamou M, et al
    Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:833-839.
    PubMed         Abstract available

  42. PATEL MURTHY B, Zell E, Kirtland K, Jones-Jack N, et al
    Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations - 10 U.S. Jurisdictions, March-September 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:840-845.
    PubMed         Abstract available

  43. CHRISTIE A, Henley SJ, Mattocks L, Fernando R, et al
    Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:858-864.
    PubMed         Abstract available


    N Engl J Med

  44. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    PubMed        

  45. TAKUVA S, Takalani A, Garrett N, Goga A, et al
    Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
    N Engl J Med. 2021 Jun 2. doi: 10.1056/NEJMc2107920.
    PubMed        

  46. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        

  47. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        

  48. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        

  49. TAPIA MD, Sow SO, Naficy A, Diallo F, et al
    Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
    N Engl J Med. 2021;384:2115-2123.
    PubMed         Abstract available

  50. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    PubMed        

  51. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed        

  52. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed        

  53. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    PubMed        

  54. BOURGUIGNON A, Arnold DM, Warkentin TE, Smith JW, et al
    Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMoa2107051.
    PubMed         Abstract available


  55. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021;384:e92.
    PubMed        


    Nat Med

  56. MAY M
    After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases.
    Nat Med. 2021 May 31. pii: 10.1038/s41591-021-01393.
    PubMed        

  57. SIMPSON CR, Shi T, Vasileiou E, Katikireddi SV, et al
    First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01408.
    PubMed         Abstract available

  58. PISHKO AM, Bussel JB, Cines DB
    COVID-19 vaccination and immune thrombocytopenia.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01419.
    PubMed        

  59. PRITCHARD E, Matthews PC, Stoesser N, Eyre DW, et al
    Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01410.
    PubMed         Abstract available

  60. MILMAN O, Yelin I, Aharony N, Katz R, et al
    Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.
    Nat Med. 2021 Jun 10. pii: 10.1038/s41591-021-01407.
    PubMed         Abstract available


    Pediatr Infect Dis J

  61. BICKEL S, Harris C, Huxol H, Morton R, et al
    COVID-19 Vaccination Outcomes at a Pediatric Long-Term Care Facility.
    Pediatr Infect Dis J. 2021;40:e281-e283.
    PubMed        

  62. SNAPIRI O, Rosenberg Danziger C, Shirman N, Weissbach A, et al
    Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine.
    Pediatr Infect Dis J. 2021 Jun 2. pii: 00006454-900000000-95800.
    PubMed         Abstract available

  63. CLARK DR, Omer SB, Tapia MD, Nunes MC, et al
    Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials.
    Pediatr Infect Dis J. 2020 May 1. doi: 10.1097/INF.0000000000002629.
    PubMed         Abstract available


    Pediatrics

  64. BREWER NT, Gilkey MB, Thompson P
    RE: Progress in HPV Vaccine Hesitancy.
    Pediatrics. 2021;147.
    PubMed        

  65. O'LEARY ST, Maldonado YA
    Myocarditis after SARS-CoV-2 Vaccination: True, True, and...Related?
    Pediatrics. 2021 Jun 4. pii: peds.2021-052644. doi: 10.1542/peds.2021-052644.
    PubMed        

  66. MARSHALL M, Ferguson ID, Lewis P, Jaggi P, et al
    Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination.
    Pediatrics. 2021 Jun 4. pii: peds.2021-052478. doi: 10.1542/peds.2021-052478.
    PubMed        


    PLoS Med

  67. GRAY P, Kann H, Pimenoff VN, Eriksson T, et al
    Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    PLoS Med. 2021;18:e1003588.
    PubMed         Abstract available


    PLoS One

  68. KHOU C, Diaz-Salinas MA, da Costa A, Prehaud C, et al
    Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
    PLoS One. 2021;16:e0252595.
    PubMed         Abstract available

  69. NAKPHOOK S, Patumanond J, Shrestha M, Prasert K, et al
    Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    PLoS One. 2021;16:e0253028.
    PubMed         Abstract available

  70. KAHANA D, Yamin D
    Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
    PLoS One. 2021;16:e0252510.
    PubMed         Abstract available

  71. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0252332.
    PubMed         Abstract available

  72. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  73. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  74. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  75. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  76. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Science

  77. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    PubMed        

  78. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    PubMed        


    Vaccine

  79. LILES E, Irving SA, Dandamudi P, Belongia EA, et al
    Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
    Vaccine. 2021;39:3614-3620.
    PubMed         Abstract available

  80. VANHEMS P
    A breath of humanity in the era of Covid-19 vaccine.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00638.
    PubMed        

  81. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed         Abstract available

  82. AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
    Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
    PubMed         Abstract available

  83. WAGNER NM, Dempsey AF, Narwaney KJ, Gleason KS, et al
    Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00639.
    PubMed         Abstract available

  84. FENG Y, Yao T, Chang Y, Gao L, et al
    Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
    Vaccine. 2021;39:3582-3589.
    PubMed         Abstract available

  85. VUJOVICH-DUNN C, Kaufman J, King C, Skinner SR, et al
    A systematic review and meta-analysis of effectiveness of decision aids for vaccination decision-making.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00583.
    PubMed         Abstract available

  86. VAILLANT L, Oster P, McMillan B, Velin D, et al
    Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
    Vaccine. 2021;39:3590-3601.
    PubMed         Abstract available

  87. GIDENGIL C, Goetz MB, Newberry S, Maglione M, et al
    Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
    Vaccine. 2021 May 23. pii: S0264-410X(21)00385.
    PubMed         Abstract available

  88. SATTLER C, Hoffmann P, Herzberg PY, Weber D, et al
    Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
    Vaccine. 2021 May 25. pii: S0264-410X(21)00511.
    PubMed         Abstract available

  89. MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
    Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
    Vaccine. 2021;39:3467-3472.
    PubMed         Abstract available

  90. JETHWA H, Wong R, Abraham S
    Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
    Vaccine. 2021;39:3541-3543.
    PubMed        

  91. WANG Y, Zhang Y, Wu H, Huang L, et al
    Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
    PubMed         Abstract available

  92. MCGUINNESS D, Kaufhold RM, McHugh PM, Winters MA, et al
    Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00549.
    PubMed         Abstract available

  93. GREWAL R, Deeks SL, Hart TA, Cox J, et al
    Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00603.
    PubMed         Abstract available

  94. LEWIS NS, Banyard AC, Essen S, Whittard E, et al
    Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
    PubMed         Abstract available

  95. STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
    Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
    PubMed         Abstract available

  96. CHANDRA D, Vipin B
    On the vaccine supply chain coordination under subsidy contract.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00676.
    PubMed         Abstract available

  97. ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
    Myocarditis following COVID-19 mRNA vaccination.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
    PubMed         Abstract available

  98. ITO N, Okamoto T, Sasaki M, Miyamoto S, et al
    Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00553.
    PubMed         Abstract available

  99. BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
    Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
    PubMed         Abstract available

  100. WOLFE LS, Smedley JG 3rd, Bubna N, Hussain A, et al
    Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00668.
    PubMed         Abstract available

  101. KARAFILLAKIS E, Francis MR, Paterson P, Larson HJ, et al
    Trust, emotions and risks: Pregnant women's perceptions, confidence and decision-making practices around maternal vaccination in France.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00704.
    PubMed         Abstract available

  102. NOGUERA M, Vela A, Kraft C, Chevalier M, et al
    Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00614.
    PubMed         Abstract available

  103. CHUA JV, Davis C, Husson JS, Nelson A, et al
    Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00685.
    PubMed         Abstract available

  104. UWINS C, Cyriac S, Bhandoria G
    HPV vaccine: Expanding indications and global disparity.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.
    PubMed        

  105. GATES A, Rahman S, Sim S, Pillay J, et al
    Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
    PubMed         Abstract available

  106. GURWITZ D
    COVID-19 vaccine hesitancy: Lessons from Israel.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00680.
    PubMed        

  107. BREWER NT, Mitchell CG, Alton Dailey S, Hora L, et al
    HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00610.
    PubMed         Abstract available

  108. GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
    U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
    PubMed         Abstract available

  109. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
    Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
    PubMed         Abstract available

  110. SHI M, Chen X, Sun Y, Kim HK, et al
    A protein A based Staphylococcus aureus vaccine with improved safety.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00667.
    PubMed         Abstract available

  111. JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
    Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00663.
    PubMed         Abstract available

  112. YANG T, Liu B, Yue L, Xie T, et al
    Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00653.
    PubMed         Abstract available

  113. SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
    Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
    PubMed         Abstract available

  114. LASKY T, McMahon AW, Hua W, Forshee R, et al
    Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
    PubMed         Abstract available

  115. FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
    Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
    PubMed         Abstract available

  116. ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
    Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
    Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
    PubMed         Abstract available


    Virology

  117. OH HS, Yoon JW, Lee S, Kim SO, et al
    A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
    Virology. 2021;560:124-130.
    PubMed         Abstract available


    Virus Res

  118. DOERFLER W
    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: